Galmed Pharmaceuticals Rebrands as EoCene, Adopts Ticker EOCN
Galmed Pharmaceuticals rebrands as EoCene with new ticker EOCN, terminates its Yorkville SEPA and regains Nasdaq minimum bid price compliance.
Eocene Pharmaceuticals | 11/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy